Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
NCT06623201
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Basal Cell Carcinoma (BCC)
Interventions
DRUG:
aminolevulinic acid HCL (ALA)
DEVICE:
BLU-U device model 4170E
Sponsor
Nathalie Zeitouni